About Shire UK
UK is an indirect wholly owned subsidiary of Shire plc, a global specialty
biopharmaceutical company that works closely with specialist physicians, nurses,
pharmacists and other healthcare professionals to develop and market medicines
that improve quality of life for patients, their families and carers.
Shire UK currently focuses on the following therapeutic areas:
Shire traces its history back to 1986, when a team of entrepreneurs began to
capitalize on a number of unmet medical needs. Within its first two years of
operation the UK-based specialty pharmaceutical company had launched a range of
supplemental calcium products for patients seeking to treat or prevent
osteoporosis. Soon thereafter innovative drug development programs were under
way on behalf of patients facing such challenging conditions as Alzheimer’s and
end-stage renal failure.
The UK operation now comprises this original product range, additional
speciality pharmaceuticals as well as therapies for genetic disorders.
Through the commitment of our
employees, we are aiming to make a difference to patients, their families
and carers, as well as to the medical community.
Shire UK operations are based in Basingstoke, UK.
For information about Shire’s commitment to Transparency and adherence to the
Association of British Pharmaceutical Industry (ABPI) Code of Practice, please
visit Shire’s global corporate website